Cargando…

Effect of Shengmai Yin on the DNA methylation status of nasopharyngeal carcinoma cell and its radioresistant strains

Shengmai Yin (SMY) is a Chinese herbal decoction that effectively alleviates the side effects of radiotherapy in various cancers and helps achieve radiotherapy's clinical efficacy. In this study, we explored the interaction mechanism among SMY, DNA methylation, and nasopharyngeal carcinoma (NPC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shiya, Wang, Zhiyuan, Zhu, Daoqi, Yang, Jiabin, Lou, Dandan, Gao, Ruijiao, Wang, Zetai, Li, Aiwu, Lv, Ying, Fan, Qin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Xi'an Jiaotong University 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8740367/ https://www.ncbi.nlm.nih.gov/pubmed/35028184 http://dx.doi.org/10.1016/j.jpha.2020.11.010

Ejemplares similares

Effect of Shengmai Yin on Epithelial-Mesenchymal Transition of Nasopharyngeal Carcinoma Radioresistant Cells
por: Wang, Ze-tai, et al.
Publicado: (2022)

Curcumin Enhances Radiosensitization of Nasopharyngeal Carcinoma via Mediating Regulation of Tumor Stem-like Cells by a CircRNA Network
por: Zhu, Daoqi, et al.
Publicado: (2020)

Shengmai Yin formula modulates the gut microbiota of spleen-deficiency rats
por: You, Yu, et al.
Publicado: (2020)

Exploring the mechanism of Shengmai Yin for coronary heart disease based on systematic pharmacology and chemoinformatics
por: Jiang, Yan, et al.
Publicado: (2020)

Interaction between Warfarin and the Herbal Product Shengmai-Yin: A Case Report of Intracerebral Hematoma
por: Su, Qun, et al.
Publicado: (2010)

Huangqi Shengmai Yin Ameliorates Myocardial Fibrosis by Activating Sirtuin3 and Inhibiting TGF-β/Smad Pathway
por: Pan, Jianheng, et al.
Publicado: (2021)

Protective Effects of Huangqi Shengmai Yin on Type 1 Diabetes-Induced Cardiomyopathy by Improving Myocardial Lipid Metabolism
por: Cao, Zhanhong, et al.
Publicado: (2021)

Huangqi Shengmai Yin Protects against Radiation-Induced Cardiac Fibrosis Injury by Regulating the TGF-β1/Smads and MMPs
por: Gu, Jing, et al.
Publicado: (2019)

Baicalin reverses radioresistance in nasopharyngeal carcinoma by downregulating autophagy
por: Wang, Cong, et al.
Publicado: (2020)

Twist1 promotes radioresistance in nasopharyngeal carcinoma
por: Zhang, Linli, et al.
Publicado: (2016)

Multiple Mechanisms Involving in Radioresistance of Nasopharyngeal Carcinoma
por: Zhan, Yuting, et al.
Publicado: (2020)

Reduced QSOX1 enhances radioresistance in nasopharyngeal carcinoma
por: Zhou, Lei, et al.
Publicado: (2017)

Inhibition of livin overcomes radioresistance in nasopharyngeal carcinoma cells
por: Ma, Fei, et al.
Publicado: (2020)

The Inhibition of the Components from Shengmai Injection towards UDP-Glucuronosyltransferase
por: Jiang, Li-Peng, et al.
Publicado: (2014)

Investigation of the Mechanism of Shengmai Injection on Sepsis by Network Pharmacology Approaches
por: Lu, Juan, et al.
Publicado: (2020)

LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

In vivo and in vitro protective effects of shengmai injection against doxorubicin-induced cardiotoxicity
por: Zhou, Peng, et al.
Publicado: (2022)

Involvement of Non-Coding RNAs in Chemo- and Radioresistance of Nasopharyngeal Carcinoma
por: Xiao, Jiaxin, et al.
Publicado: (2021)

Traditional Chinese Medicine: A Class of Potentially Reliable Epigenetic Drugs
por: Zhu, Daoqi, et al.
Publicado: (2022)

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein
por: Liang, Yan, et al.
Publicado: (2014)

Evaluation of Potential Herb-Drug Interactions Between Shengmai Injection and Losartan Potassium in Rat and In Vitro
por: Niu, Zhenchao, et al.
Publicado: (2022)

Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21
por: Wu, Cheng, et al.
Publicado: (2020)

RPA3 is a potential marker of prognosis and radioresistance for nasopharyngeal carcinoma
por: Qu, Chen, et al.
Publicado: (2017)

Comprehensive analysis of key genes and microRNAs in radioresistant nasopharyngeal carcinoma
por: Guo, Ya, et al.
Publicado: (2019)

Shengmai San Ameliorates Myocardial Dysfunction and Fibrosis in Diabetic db/db Mice
por: Zhao, Juan, et al.
Publicado: (2016)

A Metabolomic Study of Rats with Doxorubicin-Induced Cardiomyopathy and Shengmai Injection Treatment
por: Chen, Yu, et al.
Publicado: (2015)

Prediction the Molecular Mechanism of Shengmai Injection in Acute Treatment of COVID-19 Based on Network Pharmacology
por: Wang, Chen, et al.
Publicado: (2022)

Key radioresistance regulation models and marker genes identified by integrated transcriptome analysis in nasopharyngeal carcinoma
por: Sun, Zhuang, et al.
Publicado: (2021)

ShengMai-San Attenuates Cardiac Remodeling in Diabetic Rats by Inhibiting NOX-Mediated Oxidative Stress
por: Lu, Yanting, et al.
Publicado: (2021)

Effect of repeated Shengmai-San administration on nifedipine pharmacokinetics and the risk/benefit under co-treatment
por: Wang, Hong-Jaan, et al.
Publicado: (2022)

Efficacy and Safety of Shengmai Injection for Chronic Heart Failure: A Systematic Review of Randomized Controlled Trials
por: Wang, Yanping, et al.
Publicado: (2020)

Knockdown of Annexin A1 Enhances Radioresistance and Inhibits Apoptosis in Nasopharyngeal Carcinoma
por: Liao, Li, et al.
Publicado: (2018)

Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity
por: Yuan, Li, et al.
Publicado: (2016)

Silencing hTERT attenuates cancer stem cell-like characteristics and radioresistance in the radioresistant nasopharyngeal carcinoma cell line CNE-2R
por: Chen, Kaihua, et al.
Publicado: (2020)

Efficacy and safety of Shengmai injection as an adjunctive therapy on sepsis: A protocol for systematic review and meta-analysis
por: Han, Yue, et al.
Publicado: (2022)

Bélver Yin /
por: Ferrero, Jesús, 1952-
Publicado: (1993)

BPIFB1 (LPLUNC1) inhibits radioresistance in nasopharyngeal carcinoma by inhibiting VTN expression
por: Wei, Fang, et al.
Publicado: (2018)

Discovering biomarkers of radioresistance in a radiosensitive cancer: a clinical paradox in nasopharyngeal carcinoma
por: Tan, Laura L. Y., et al.
Publicado: (2020)

miR-181a Upregulation Promotes Radioresistance of Nasopharyngeal Carcinoma by Targeting RKIP
por: Huang, Wei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_raav5p67bal48rmacu1i8ka54h